Home/Filings/4/0001209191-10-024150
4//SEC Filing

Hawi Amale 4

Accession 0001209191-10-024150

CIK 0001047188other

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 10:03 AM ET

Size

7.1 KB

Accession

0001209191-10-024150

Insider Transaction Report

Form 4
Period: 2010-04-28
Hawi Amale
SVP, Pharmaceutical Dev.
Transactions
  • Exercise/Conversion

    Common stock

    2010-04-28$1.56/sh+6,500$10,1406,500 total
  • Exercise/Conversion

    Stock Option (Right-to-Buy)

    2010-04-286,50058,500 total
    Exercise: $1.56From: 2010-03-05Exp: 2019-03-05Common Stock (6,500 underlying)

Issuer

PENWEST PHARMACEUTICALS CO

CIK 0001047188

Entity typeother

Related Parties

1
  • filerCIK 0001397456

Filing Metadata

Form type
4
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 10:03 AM ET
Size
7.1 KB